Gene therapy for bone engineering

Frontiers in Bioengineering and Biotechnology

Volumn 3, Issue FEB, 2015, Pages

  Balmayor, Elizabeth Rosado ^a,b   van Griensven, Martijn ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

Adenovirus; Bone morphogenetic proteins; Bone regeneration; Gene therapy; Hydrogel; Sonoporation

Indexed keywords

EID: 85022214800     PISSN: None     EISSN: 22964185     Source Type: Journal    
DOI: 10.3389/fbioe.2015.00009     Document Type: Review

References (83)

1. Ardjomandi, N., Niederlaender, J., Aicher, W. K., Reinert, S., Schweizer, E., Wendel, H. P., et al. (2013). Identification of an aptamer binding to human osteogenic-induced progenitor cells. Nucleic Acid Ther. 23, 44-61. doi: 10.1089/nat.2012.0349.
2. Baltzer, A. W., Lattermann, C., Whalen, J. D., Wooley, P., Weiss, K., Grimm, M., et al. (2000). Genetic enhancement of fracture repair: healing of an experimental segmental defect by adenoviral transfer of the BMP-2 gene. Gene Ther. 7, 734-739. doi:10.1038/sj.gt.3301166.
3. Beckwith, J. (1969). Scientists isolate single gene in step to heredity control. The New York Times. 72.
4. Betz, O. B., Betz, V. M., Nazarian, A., Egermann, M., Gerstenfeld, L. C., Einhorn, T. A., et al. (2007a). Delayed administration of adenoviral BMP-2 vector improves the formation of bone in osseous defects. Gene Ther. 14, 1039-1044. doi:10.1038/sj.gt.3302956.
5. Betz, V. M., Betz, O. B., Glatt, V., Gerstenfeld, L. C., Einhorn, T. A., Bouxsein, M. L., et al. (2007b). Healing of segmental bone defects by direct percutaneous gene delivery: effect of vector dose. Hum. Gene Ther. 18, 907-915. doi:10.1089/hum.2007.077.
6. Betz, O. B., Betz, V. M., Nazarian, A., Pilapil, C. G., Vrahas, M. S., Bouxsein, M. L., et al. (2006). Direct percutaneous gene delivery to enhance healing of segmental bone defects. J. Bone Joint Surg. Am. 88, 355-365. doi:10.2106/JBJS.E.00464.
7. Betz, O. B., Betz, V. M., Schroder, C., Penzkofer, R., Gottlinger, M., Mayer-Wagner, S., et al. (2013). Repair of large segmental bone defects: BMP-2 gene activated muscle grafts vs. autologous bone grafting. BMC Biotechnol. 13:65. doi:10.1186/1472-6750-13-65.
8. Bhat, B. M., Robinson, J. A., Coleburn, V. E., Zhao, W., and Kharode, Y. (2008). Evidence of in vivo osteoinduction in adult rat bone by adeno-Runx2 intra-femoral delivery. J. Cell. Biochem. 103, 1912-1924. doi:10.1002/jcb.21581.
9. Brydone, A. S., Meek, D., and Maclaine, S. (2010). Bone grafting, orthopaedic biomaterials, and the clinical need for bone engineering. Proc. Inst. Mech. Eng. H 224, 1329-1343. doi:10.1243/09544119JEIM770.
10. Burnet, M. (1971). Genes, Dreams and Reality. New York, NY: Basic Books.
11. Carragee, E. J., Chu, G., Rohatgi, R., Hurwitz, E. L., Weiner, B. K., Yoon, S. T., et al. (2013). Cancer risk after use of recombinant bone morphogenetic protein-2 for spinal arthrodesis. J. Bone Joint Surg. Am. 95, 1537-1545. doi:10.2106/jbjs.l.01483.
12. Carragee, E. J., Mitsunaga, K. A., Hurwitz, E. L., and Scuderi, G. J. (2011). Retrograde ejaculation after anterior lumbar interbody fusion using rhBMP-2: a cohort controlled study. Spine J. 11, 511-516. doi:10.1016/j.spinee.2011.02.013.
13. Chang, S. C., Chung, H. Y., Tai, C. L., Chen, P. K., Lin, T. M., and Jeng, L. B. (2010). Repair of large cranial defects by hBMP-2 expressing bone marrow stromal cells: comparison between alginate and collagen type I systems. J. Biomed. Mater. Res. A 94, 433-441. doi:10.1002/jbm.a.32685.
14. Comer, G. C., Smith, M. W., Hurwitz, E. L., Mitsunaga, K. A., Kessler, R., and Carragee, E. J. (2012). Retrograde ejaculation after anterior lumbar interbody fusion with and without bone morphogenetic protein-2 augmentation: a 10-year cohort controlled study. Spine J. 12, 881-890. doi:10.1016/j.spinee.2012.09.040.
15. Cooper, G. S., and Kou, T. D. (2013). Risk of cancer after lumbar fusion surgery with recombinant human bone morphogenic protein-2 (rh-BMP-2). Spine 38, 1862-1868. doi:10.1097/BRS.0b013e3182a3d3b4.
16. Dai, K. R., Xu, X. L., Tang, T. T., Zhu, Z. A., Yu, C. F., Lou, J. R., et al. (2005). Repairing of goat tibial bone defects with BMP-2 gene-modified tissue-engineered bone. Calcif. Tissue Int. 77, 55-61. doi:10.1007/s00223-004-0095-z.
17. Deng, Y., Bi, X., Zhou, H., You, Z., Wang, Y., Gu, P., et al. (2014). Repair of critical-sized bone defects with anti-miR-31-expressing bone marrow stromal stem cells and poly(glycerol sebacate) scaffolds. Eur. Cell. Mater. 27, 13-24.
18. des Rieux, A., Shikanov, A., and Shea, L. D. (2009). Fibrin hydrogels for non-viral vector delivery in vitro. J. Control Release 136, 148-154. doi:10.1016/j.jconrel.2009.02.004.
19. Egermann, M., Baltzer, A. W., Adamaszek, S., Evans, C., Robbins, P., Schneider, E., et al. (2006a). Direct adenoviral transfer of bone morphogenetic protein-2 cDNA enhances fracture healing in osteoporotic sheep. Hum. Gene Ther. 17, 507-517. doi:10.1089/hum.2006.17.507.
20. Egermann, M., Lill, C. A., Griesbeck, K., Evans, C. H., Robbins, P. D., Schneider, E., et al. (2006b). Effect of BMP-2 gene transfer on bone healing in sheep. Gene Ther. 13, 1290-1299. doi:10.1038/sj.gt.3302785.
21. Elsabahy, M., Nazarali, A., and Foldvari, M. (2011). Non-viral nucleic acid delivery: key challenges and future directions. Curr. Drug Deliv. 8, 235-244. doi:10.2174/156720111795256174.
22. Evans, C. H. (2012). Gene delivery to bone. Adv. Drug Deliv. Rev. 64, 1331-1340. doi:10.1016/j.addr.2012.03.013.
23. Evans, C. H., Liu, F. J., Glatt, V., Hoyland, J. A., Kirker-Head, C., Walsh, A., et al. (2009). Use of genetically modified muscle and fat grafts to repair defects in bone and cartilage. Eur. Cell. Mater. 18, 96-111.
24. Feichtinger, G. A., Hacobian, A., Hofmann, A. T., Wassermann, K., Zimmermann, A., Van Griensven, M., et al. (2014a). Constitutive and inducible co-expression systems for non-viral osteoinductive gene therapy. Eur. Cell. Mater. 27, 166-184.
25. Feichtinger, G. A., Hofmann, A. T., Slezak, P., Schuetzenberger, S., Kaipel, M., Schwartz, E., et al. (2014b). Sonoporation increases therapeutic efficacy of inducible and constitutive BMP2/7 in vivo gene delivery. Hum. Gene Ther. Methods 25, 57-71. doi:10.1089/hgtb.2013.113.
26. Fu, R., Selph, S., McDonagh, M., Peterson, K., Tiwari, A., Chou, R., et al. (2013). Effectiveness and harms of recombinant human bone morphogenetic protein-2 in spine fusion: a systematic review and meta-analysis. Ann. Intern. Med. 158, 890-902. doi:10.7326/0003-4819-158-12-201306180-00006.
27. Gaston, M. S., and Simpson, A. H. (2007). Inhibition of fracture healing. J. Bone Joint Surg. Br. 89, 1553-1560. doi:10.1302/0301-620X.89B12.19671.
28. Giannoudis, P. V., Einhorn, T. A., and Marsh, D. (2007). Fracture healing: the diamond concept. Injury 38(Suppl. 4), S3-S6. doi:10.1016/S0020-1383(08)70003-2.
29. Hong, L., Wei, N., Joshi, V., Yu, Y., Kim, N., Krishnamachari, Y., et al. (2012). Effects of glucocorticoid receptor small interfering RNA delivered using poly lactic-co-glycolic acid microparticles on proliferation and differentiation capabilities of human mesenchymal stromal cells. Tissue Eng. Part A 18, 775-784. doi:10.1089/ten. TEA.2011.0432.
30. Huang, Y. C., Kaigler, D., Rice, K. G., Krebsbach, P. H., and Mooney, D. J. (2005). Combined angiogenic and osteogenic factor delivery enhances bone marrow stromal cell-driven bone regeneration. J. Bone Miner. Res. 20, 848-857. doi:10.1359/jbmr.041226.
31. Jain, S., Kumar, S., Agrawal, A. K., Thanki, K., and Banerjee, U. C. (2013). Enhanced transfection efficiency and reduced cytotoxicity of novel lipid-polymer hybrid nanoplexes. Mol. Pharm. 10, 2416-2425. doi:10.1021/mp400036w.
32. Jia, S., Yang, X., Song, W., Wang, L., Fang, K., Hu, Z., et al. (2014). Incorporation of osteogenic and angiogenic small interfering RNAs into chitosan sponge for bone tissue engineering. Int. J. Nanomedicine 9, 5307-5316. doi:10.2147/ijn.s70457.
33. Kaempfer, R. (2003). RNA sensors: novel regulators of gene expression. EMBO Rep. 4, 1043-1047. doi:10.1038/sj.embor.embor7400005.
34. Kaeppel, C., Beattie, S. G., Fronza, R., Van Logtenstein, R., Salmon, F., Schmidt, S., et al. (2013). A largely random AAV integration profile after LPLD gene therapy. Nat. Med. 19, 889-891. doi:10.1038/nm.3230.
35. Kaipel, M., Schutzenberger, S., Hofmann, A. T., Ferguson, J., Nau, T., Redl, H., et al. (2014). Evaluation of fibrin-based gene-activated matrices for BMP2/7 plasmid codelivery in a rat nonunion model. Int. Orthop. 38, 2607-2613. doi:10.1007/s00264-014-2499-3.
36. Kawakami, Y., Ii, M., Matsumoto, T., Kawamoto, A., Kuroda, R., Akimaru, H., et al. (2013). A small interfering RNA targeting Lnk accelerates bone fracture healing with early neovascularization. Lab. Invest. 93, 1036-1053. doi:10.1038/labinvest.2013.93.
37. Kelly, M. P., Savage, J. W., Bentzen, S. M., Hsu, W. K., Ellison, S. A., and Anderson, P. A. (2014). Cancer risk from bone morphogenetic protein exposure in spinal arthrodesis. J. Bone Joint Surg. Am. 96, 1417-1422. doi:10.2106/jbjs.m.01190.
38. Lederberg, J. (1968). DNA breakthrough points way to therapy by virus. Washington Post.
39. Lei, Y., Huang, S., Sharif-Kashani, P., Chen, Y., Kavehpour, P., and Segura, T. (2010). Incorporation of active DNA/cationic polymer polyplexes into hydrogel scaffolds. Biomaterials 31, 9106-9116. doi:10.1016/j.biomaterials.2010.08.016.
40. Lei, Y., Rahim, M., Ng, Q., and Segura, T. (2011). Hyaluronic acid and fibrin hydrogels with concentrated DNA/PEI polyplexes for local gene delivery. J. Control Release 153, 255-261. doi:10.1016/j.jconrel.2011.01.028.
41. Li, Y., Fan, L., Liu, S., Liu, W., Zhang, H., Zhou, T., et al. (2013). The promotion of bone regeneration through positive regulation of angiogenic-osteogenic coupling using microRNA-26a. Biomaterials 34, 5048-5058. doi:10.1016/j.biomaterials.2013.03.052.
42. Li, Y. S., Davidson, E., Reid, C. N., and McHale, A. P. (2009). Optimising ultrasound-mediated gene transfer (sonoporation) in vitro and prolonged expression of a transgene in vivo: potential applications for gene therapy of cancer. Cancer Lett. 273, 62-69. doi:10.1016/j.canlet.2008.07.030.
43. Lian, J. B., Stein, G. S., Stein, J. L., and Van Wijnen, A. J. (2000). Marrow transplantation and targeted gene therapy to the skeleton. Clin. Orthop. Relat. Res. (Suppl. 379):S146-S155. doi:10.1097/00003086-200010001-00019.
44. Lieberman, J. R., Daluiski, A., Stevenson, S., Wu, L., McAllister, P., Lee, Y. P., et al. (1999). The effect of regional gene therapy with bone morphogenetic protein-2-producing bone-marrow cells on the repair of segmental femoral defects in rats. J. Bone Joint Surg. Am. 81, 905-917.
45. Locatelli, P., Olea, F. D., Hnatiuk, A., Sepulveda, D., Perez Saez, J. M., Arguello, R., et al. (2013). Efficient plasmid-mediated gene transfection of ovine bone marrow mesenchymal stromal cells. Cytotherapy 15, 163-170. doi:10.1016/j.jcyt.2012.11.004.
46. Loh, X. J., and Lee, T. C. (2012). Gene delivery by functional inorganic nanocarriers. Recent Pat. DNA Gene Seq. 6, 108-114. doi:10.2174/187221512801327361.
47. Medina-Kauwe, L. K., Xie, J., and Hamm-Alvarez, S. (2005). Intracellular trafficking of nonviral vectors. Gene Ther. 12, 1734-1751. doi:10.1038/sj.gt.3302592.
48. Mehier-Humbert, S., Bettinger, T., Yan, F., and Guy, R. H. (2005). Ultrasound-mediated gene delivery: kinetics of plasmid internalization and gene expression. J. Control Release 104, 203-211. doi:10.1016/j.jconrel.2005.01.011.
49. Mingozzi, F., and High, K. A. (2013). Immune responses to AAV vectors: overcoming barriers to successful gene therapy. Blood 122, 23-36. doi:10.1182/blood-2013-01-306647.
50. Nguyen, M. K., Jeon, O., Krebs, M. D., Schapira, D., and Alsberg, E. (2014). Sustained localized presentation of RNA interfering molecules from in situ forming hydrogels to guide stem cell osteogenic differentiation. Biomaterials 35, 6278-6286. doi:10.1016/j.biomaterials.2014.04.048.
51. Osawa, K., Okubo, Y., Nakao, K., Koyama, N., and Bessho, K. (2009). Osteoinduction by microbubble-enhanced transcutaneous sonoporation of human bone morphogenetic protein-2. J. Gene Med. 11, 633-641. doi:10.1002/jgm.1331.
52. Park, J., Ries, J., Gelse, K., Kloss, F., Von Der Mark, K., Wiltfang, J., et al. (2003). Bone regeneration in critical size defects by cell-mediated BMP-2 gene transfer: a comparison of adenoviral vectors and liposomes. Gene Ther. 10, 1089-1098. doi:10.1038/sj.gt.3301960.
53. Peterson, B., Zhang, J., Iglesias, R., Kabo, M., Hedrick, M., Benhaim, P., et al. (2005). Healing of critically sized femoral defects, using genetically modified mesenchymal stem cells from human adipose tissue. Tissue Eng. 11, 120-129. doi:10.1089/ten.2005.11.120.
54. Rios, C. N., Skoracki, R. J., and Mathur, A. B. (2012). GNAS1 and PHD2 short-interfering RNA support bone regeneration in vitro and in an in vivo sheep model. Clin. Orthop. Relat. Res. 470, 2541-2553. doi:10.1007/s11999-012-2475-4.
55. Samee, M., Kasugai, S., Kondo, H., Ohya, K., Shimokawa, H., and Kuroda, S. (2008). Bone morphogenetic protein-2 (BMP-2) and vascular endothelial growth factor (VEGF) transfection to human periosteal cells enhances osteoblast differentiation and bone formation. J. Pharmacol. Sci. 108, 18-31. doi:10.1254/jphs.08036FP.
56. Santos, J. L., Oramas, E., Pego, A. P., Granja, P. L., and Tomas, H. (2009). Osteogenic differentiation of mesenchymal stem cells using PAMAM dendrimers as gene delivery vectors. J. Control Release 134, 141-148. doi:10.1016/j.jconrel.2008.11.007.
57. Sarker, S. R., Aoshima, Y., Hokama, R., Inoue, T., Sou, K., and Takeoka, S. (2013). Arginine-based cationic liposomes for efficient in vitro plasmid DNA delivery with low cytotoxicity. Int. J. Nanomedicine 8, 1361-1375. doi:10.2147/IJN.S38903.
58. Schade, A., Delyagina, E., Scharfenberg, D., Skorska, A., Lux, C., David, R., et al. (2013). Innovative strategy for microRNA delivery in human mesenchymal stem cells via magnetic nanoparticles. Int. J. Mol. Sci. 14, 10710-10726. doi:10.3390/ijms140610710.
59. Schade, A., Muller, P., Delyagina, E., Voronina, N., Skorska, A., Lux, C., et al. (2014). Magnetic nanoparticle based nonviral microRNA delivery into freshly isolated CD105(+) hMSCs. Stem Cells Int. 2014, 197154. doi:10.1155/2014/197154.
60. Schillinger, U., Wexel, G., Hacker, C., Kullmer, M., Koch, C., Gerg, M., et al. (2008). A fibrin glue composition as carrier for nucleic acid vectors. Pharm. Res. 25, 2946-2962. doi:10.1007/s11095-008-9719-8.
61. Schleef, M., Blaesen, M., Schmeer, M., Baier, R., Marie, C., Dickson, G., et al. (2010). Production of non viral DNA vectors. Curr. Gene Ther. 10, 487-507. doi:10.2174/156652310793797711.
62. Seeliger, C., Karpinski, K., Haug, A. T., Vester, H., Schmitt, A., Bauer, J. S., et al. (2014). Five freely circulating miRNAs and bone tissue miRNAs are associated with osteoporotic fractures. J. Bone Miner. Res. 29, 1718-1728. doi:10.1002/jbmr.2175.
63. Sen, C. K. (2011). MicroRNAs as new maestro conducting the expanding symphony orchestra of regenerative and reparative medicine. Physiol. Genomics 43, 517-520. doi:10.1152/physiolgenomics.00037.2011.
64. Shan, Y., Luo, T., Peng, C., Sheng, R., Cao, A., Cao, X., et al. (2012). Gene delivery using dendrimer-entrapped gold nanoparticles as nonviral vectors. Biomaterials 33, 3025-3035. doi:10.1016/j.biomaterials.2011.12.045.
65. Sheyn, D., Kimelman-Bleich, N., Pelled, G., Zilberman, Y., Gazit, D., and Gazit, Z. (2008). Ultrasound-based nonviral gene delivery induces bone formation in vivo. Gene Ther. 15, 257-266. doi:10.1038/sj.gt.3303070.
66. Shum, K. T., Chan, C., Leung, C. M., and Tanner, J. A. (2011). Identification of a DNA aptamer that inhibits sclerostin's antagonistic effect on Wnt signalling. Biochem. J. 434, 493-501. doi:10.1042/bj20101096.
67. Smucker, J. D., Rhee, J. M., Singh, K., Yoon, S. T., and Heller, J. G. (2006). Increased swelling complications associated with off-label usage of rhBMP-2 in the anterior cervical spine. Spine 31, 2813-2819. doi:10.1097/01.brs.0000245863.52371.c2.
68. Sonnet, C., Simpson, C. L., Olabisi, R. M., Sullivan, K., Lazard, Z., Gugala, Z., et al. (2013). Rapid healing of femoral defects in rats with low dose sustained BMP2 expression from PEGDA hydrogel microspheres. J. Orthop. Res. 31, 1597-1604. doi:10.1002/jor.22407.
69. Tarkka, T., Sipola, A., Jamsa, T., Soini, Y., Yla-Herttuala, S., Tuukkanen, J., et al. (2003). Adenoviral VEGF-A gene transfer induces angiogenesis and promotes bone formation in healing osseous tissues. J. Gene Med. 5, 560-566. doi:10.1002/jgm.392.
70. Tatum, E. L. (1966). Molecular biology, nucleic acids, and the future of medicine. Perspect. Biol. Med. 10, 19-32. doi:10.1353/pbm.1966.0027.
71. Tros de Ilarduya, C., Sun, Y., and Düzgünes, N. (2010). Gene delivery by lipoplexes and polyplexes. Eur. J. Pharm. Sci. 40, 159-170. doi:10.1016/j.ejps.2010.03.019.
72. Tsuda, H., Wada, T., Ito, Y., Uchida, H., Dehari, H., Nakamura, K., et al. (2003). Efficient BMP2 gene transfer and bone formation of mesenchymal stem cells by a fiber-mutant adenoviral vector. Mol. Ther. 7, 354-365. doi:10.1016/S1525-0016(02)00062-X.
73. van Griensven, M., Lobenhoffer, P., Barke, A., Tschernig, T., Lindenmaier, W., Krettek, C., et al. (2002). Adenoviral gene transfer in a rat fracture model. Lab. Anim. 36, 455-461. doi:10.1258/002367702320389134.
74. van Wijnen, A. J., Van De Peppel, J., Van Leeuwen, J. P., Lian, J. B., Stein, G. S., Westendorf, J. J., et al. (2013). MicroRNA functions in osteogenesis and dysfunctions in osteoporosis. Curr. Osteoporos. Rep. 11, 72-82. doi:10.1007/s11914-013-0143-6.
75. Wegman, F., Bijenhof, A., Schuijff, L., Oner, F. C., Dhert, W. J., and Alblas, J. (2011). Osteogenic differentiation as a result of BMP-2 plasmid DNA based gene therapy in vitro and in vivo. Eur. Cell. Mater. 21, 230-242.
76. Wolff, J. A., and Lederberg, J. (1994). An early history of gene-transfer and therapy. Hum. Gene Ther. 5, 469-480. doi:10.1089/Hum.1994.5.4-469.
77. Won, Y.-W., Lim, K. S., and Kim, Y.-H. (2011). Intracellular organelle-targeted non-viral gene delivery systems. J. Control. Release 152, 99-109. doi:10.1016/j.jconrel.2011.01.013.
78. Woo, E. J. (2012). Recombinant human bone morphogenetic protein-2: adverse events reported to the manufacturer and user facility device experience database. Spine J. 12, 894-899. doi:10.1016/j.spinee.2012.09.052.
79. Wu, G. P., He, X. C., Hu, C. B., Li, D. P., Yang, Z. H., and Guo, L. (2012). Effect of electroporation-mediated transfecting recombinant plasmid pIRES-hBMP2-hVEGF165 on mandibular distraction osteogenesis. Ann. Plast. Surg. 69, 316-325. doi:10.1097/SAP.0b013e3182119275.
80. Xu, X. L., Tang, T., Dai, K., Zhu, Z., Guo, X. E., Yu, C., et al. (2005). Immune response and effect of adenovirus-mediated human BMP-2 gene transfer on the repair of segmental tibial bone defects in goats. Acta Orthop. 76, 637-646. doi:10.1080/17453670510041709.
81. Yan, J., Zhang, C., Zhao, Y., Cao, C., Wu, K., Zhao, L., et al. (2014). Non-viral oligonucleotide antimiR-138 delivery to mesenchymal stem cell sheets and the effect on osteogenesis. Biomaterials 35, 7734-7749. doi:10.1016/j.biomaterials.2014.05.089.
82. Yang, H. S., La, W. G., Cho, Y. M., Shin, W., Yeo, G. D., and Kim, B. S. (2012). Comparison between heparin-conjugated fibrin and collagen sponge as bone morphogenetic protein-2 carriers for bone regeneration. Exp. Mol. Med. 44, 350-355. doi:10.3858/emm.2012.44.5.039.
83. Zhang, Y., Fan, W., Nothdurft, L., Wu, C., Zhou, Y., Crawford, R., et al. (2011). In vitro and in vivo evaluation of adenovirus combined silk fibroin scaffolds for bone morphogenetic protein-7 gene delivery. Tissue Eng. Part C Methods 17, 789-797. doi:10.1089/ten.tec.2010.0453.